Economists expected US GDP to expand by a 3% annual rate during the fourth quarter. It didn’t — instead expanding at a 2.8% clip. Traders immediately sold futures, only to buy back stocks an hour later when the market opened. We should continue to expect this tug-of-war between bulls and bears to continue for a …read more
Why Investors Flock to the Penny Sleuth...
The Penny Sleuth is your independent, in-depth, unbiased source on penny stocks, options, microcaps, pink sheet stocks, the OTCBB and securities. In our e-letter you’ll find analysis on some of the smallest, fastest moving growth stocks on the market.
It’s all we do — even though the mainstream financial media avoid these stocks like the plague. The Penny Sleuth teams makes sure you are the first to know about any opportunity, no matter what the industry or market. We scour all types of investments — everything from new technologies and biotech discoveries to groundbreaking energy companies and commodities.
We don’t accept compensation for our coverage of these companies — we aren’t in the investor relations business. Great investment ideas are our forte, but we aren’t financial advisers. If you need personal investment advice, contact your broker. Also, we don’t own any positions — long or short — in any of the stocks we recommend in any of our trading services. And we make it a point to disclose our ownership in companies we mention in any of our Penny Sleuth columns.
Sign up for the FREE Penny Sleuth e-letter and receive issues delivered straight to your inbox!
This is probably my favorite special situation of all for its simplicity. Joel Greenblatt wrote about it in his 1997 book You Can Be a Stock Market Genius. Greenblatt, at that time, was a relative unknown. But his Gotham Capital had put up 50% average annual returns for 10 years. The ...read more
The business of medical biotechnologies operates within an extraordinarily complex regulatory system. The SEC and the IRS are only the beginning of the story... In the United States, the Food and Drug Administration determines what can legally be sold. It even exercises control over what can be said by companies about medical ...read more
Successful trading hinges on the ability to spot meaningful turning points in sentiment and exploiting these important emotional periods during the beginning stages of a new trend. With the major averages flirting with key breakout levels, you need to be able to analyze how market participants will react to higher ...read more
I am seeing a ton of bullish setups this week. It’s more than I’ve seen in a long time — maybe the most since late winter 2011. It’s exciting to see stocks attempting breakouts again, yet worrisome at the same time. As much as I want to be bullish here, I’m ...read more
When you spend your days dissecting countless stocks, you sometimes stumble upon small groups of similar companies having their own private bull market. Often, the momentum can be traced back to an obvious catalyst — fundamental improvements within the group or a well-publicized buyout in the sector. But sometimes, investors and ...read more
If you’re just starting out as a trader, the sheer number of technical analysis patterns can be downright overwhelming. With literally hundreds of patterns to look for anytime you analyze a chart, it’s no surprise that new technical traders often suffer from analysis paralysis when they’re just starting out. But it ...read more
My colleague Ray Blanco and I are back from the Consumer Electronics Show (CES) in Las Vegas. The big story this year was the convergence in consumer electronics. Specifically, it was the arrival of extraordinary high-definition 3-D as well as “smart” TVs. In fact, Ray and I had backstage passes ...read more
2011 was quite a year. Between threats of a second global meltdown, violent price swings in stocks and political incompetence, investors have faced an uphill climb to just to stay at breakeven. Don’t let the financial media fool you with talk of market changes right away — as far as ...read more
